Equity Research, Broker Reports, and media content on Shield Therapeutics Plc

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Shield Therapeutics Plc
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Shield Therapeutics Plc

Company Profile

  • Personnel
  • Tim Watts, CEO

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Shield Therapeutics Plc. We currently have 132 research reports from 8 professional analysts.

  • Open: 132p
  • Range Today: 128/133p
  • 52 Week: 39.1/195p
  • Daily Volume: 37.5k
  • Daily Liquidity: (0.03%)
  • # Shares: 117.2m
  • Market Cap: £151.8m
  • Latest PE (hist):
  • Div Yield:
Date Source Announcement
30Sep20 13:21 RNS Block Listing 6 Monthly Return
30Sep20 13:20 RNS Total Voting Rights Update
18Sep20 13:30 EQS Hardman & Co Research: Shield Therapeutics (STX): Optimism over US deal
16Sep20 07:00 RNS Half-year Report
14Sep20 07:00 RNS Notice of Results
28Aug20 12:21 RNS Total Voting Rights Update
06Aug20 14:21 RNS AEGIS-H2H study reanalysis
  • Frequency of research reports


  • Research reports on

    Shield Therapeutics Plc

  • Providers covering

    Shield Therapeutics Plc